Propensity score – Page 4 – Communicable Diseases Research

Statin Use and In-hospital Mortality in Patients with COVID-19 and Coronary Heart Disease

Article

Published on 2021-12-132022-10-04
Journal: Scientific Reports [Category] 임상, 치료제,

Compassionate Use of Hydroxychloroquine in Clinical Practice for Patients With Mild to Severe COVID-19 in a French University Hospital

프랑스 대학 병원의 경증 내지 중증 COVID-19 환자를 위한 임상 실습에서 하이드록시클로로퀸의 자비로운 사용

Observational Study

Published on 2021-12-062022-09-11
Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 신약개발, 임상,

[키워드] addition Admission age Analysis analyzed Arterial hypertension Charlson Comorbidity Index clinical Comorbidity conducted confidence interval confounder confounders contraindication contraindications Controlled trial coronavirus disease Coronavirus disease 2019 COVID-19 death decision defined determine dosage effective French group hazard ratio help Hospitalized Hydroxychloroquine hypertension initial intensive care intensive care unit laboratory-confirmed Laboratory-confirmed COVID-19 medical history Mild National Early Warning Score NEWS2 Nonrandomized studies nonrandomized study not significantly different obesity outcome overall survival Patient patients treated Pneumonia Practice primary analysis primary endpoint Propensity score reduced risk reduction retrospective cohort study risk SARS-CoV-2 score severe COVID-19 severity Sex significantly Standard of care suggested symptom onset the mean the median therapeutic therapeutic agent Treatment treatment of COVID-19 university university hospital was performed Weighting with COVID-19
[DOI] 10.1093/cid/ciaa791 PMC 바로가기 [Article Type] Observational Study

Association Between Chronic Use of Immunosuppresive Drugs and Clinical Outcomes From Coronavirus Disease 2019 (COVID-19) Hospitalization: A Retrospective Cohort Study in a Large US Health System

Coronavirus Disease 2019 (COVID-19) 입원 : 미국의 대규모 미국 건강 시스템에서의 후 향적 코호트 연구의 만성 사용 및 임상 결과 사이의 연관성

Article

Published on 2021-12-062022-08-31
Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 치료제,

[키워드] 95% CI 95% confidence interval Admission adults hospitalized chronic clinical Clinical outcome clinical outcomes cohort study coronavirus disease Coronavirus disease 2019 COVID-19 defined discharge drug entire cohort hazard ratio health system Hospital admission Hospital mortality Immunosuppressed Immunosuppression immunosuppressive drug immunosuppressive drugs IMPROVE in-hospital mortality individual interquartile range laboratory-confirmed mechanical ventilation mechanism median age Medicines mycophenolate mycophenolate mofetil no significant difference no significant differences Patient Prednisone prescription medicines. Prescriptions Probability Propensity score retrospective cohort study risk severity study period survived System tacrolimus the median Treatment with COVID-19
[DOI] 10.1093/cid/ciaa1488 PMC 바로가기 [Article Type] Article

A Propensity Score-Matched Observational Study of Remdesivir in Patients with COVID-19 and Severe Kidney Disease

COVID-19 및 중증 신장 질환 환자에서 렘데시비르의 성향 점수 일치 관찰 연구

Observational Study

Published on 2021-12-032022-09-11
Journal: Kidney360 [Category] COVID19(2023년), SARS, 임상, 치료제,

[키워드] 1:1 Abnormalities acute kidney Acute kidney injury Adverse adverse events age Altered mental status Anemia Antiviral approved arrythmia Cardiac arrest Care Chronic kidney disease clinically Cohort Control control group controls COVID-19 creatinine defined determine Dexamethasone dialysis EGFR Emergency use authorization event explained Factor Health Health care Health care system historical control hospital Hospital admission Hospitalized hospitalized patient hyperglycemia increase in increased risk initiated kidney Kidney disease Kidney failure Kidney function Liver function Liver function test liver function test abnormalities outcome Participants Patient patients with COVID-19 Propensity score propensity scores Remdesivir retrospective cohort study risk SARS-CoV-2 significantly increased Treatment were recorded with COVID-19 women worsening
[DOI] 10.34067/KID.0006152021 PMC 바로가기 [Article Type] Observational Study

Single versus multiple doses of Tocilizumab in critically ill patients with coronavirus disease 2019 (COVID-19): A two-center, retrospective cohort study

2019년 코로나바이러스 질환(COVID-19)이 있는 중환자에서 토실리주맙의 단일 용량 대 다중 용량: 2개 센터, 후향적 코호트 연구

Multicenter Study

Published on 2021-12-012022-09-12
Journal: Journal of critical care [Category] 진단,

DrugWAS: Drug-wide Association Studies for COVID-19 Drug Repurposing

DrugWAS: COVID-19 약물 용도 변경에 대한 약물 전반의 협회 연구

Article

Published on 2021-12-012022-09-11
Journal: Clinical Pharmacology and Therapeutics [Category] MERS, 신약개발,

[키워드] 95% CI 95% confidence interval Admission Analysis applied association azelastine center clinical trials cohort study coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 diagnosis COVID-19 disease COVID-19 severity death Dextromethorphan diphtheria toxoid drug drugs Efficacy EHR EHR data Electronic health record estradiol ethinyl estradiol exposure to fatty acids Flaxseed fluticasone Health health record ibuprofen identify IMPROVE intensive care intensive care unit list lower risk mechanical ventilation multivariable logistic regression Odds ratio omega-3 Omega-3 fatty acids outcomes overlap pandemic patients with COVID-19 performed pertussis vaccine pneumococcal polysaccharide vaccine Potential treatment Primary outcome Propensity score pseudoephedrine randomized clinical trial repurposing retrospective cohort risk of death secondary Secondary analyses Secondary outcomes significantly tetanus toxoid ubidecarenone university Vaccine Vaccines was selected Weighting
[DOI] 10.1002/cpt.2376 PMC 바로가기 [Article Type] Article

Clinical outcomes of intravenous immunoglobulin therapy in COVID-19 related acute respiratory distress syndrome: a retrospective cohort study

COVID-19 관련 급성 호흡기 병원 증후군에서 정맥 내 면역 글로불린 요법의 임상 결과 : 후 향적 코호트 연구

Research

Published on 2021-11-082022-09-01
Journal: BMC Pulmonary Medicine [Category] Fulltext, MERS, 진단,

[키워드] 95% CI Acute kidney injury acute respiratory distress acute respiratory distress syndrome addition adjust AKI Analysis ARDS clinical Cohort conducted confounders coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient Electronic health record Electronic health records General Hospital groups ICU ICU mortality ICUs Immunoglobulin immunoglobulin therapy immunomodulatory therapy incidence intensive care unit intensive care units Intravenous immunoglobulin Invasive mechanical ventilation IVIG mechanical ventilation mechanically ventilated mechanically ventilated patient mechanically ventilated patients Mortality observation outcome Patient Primary outcome Propensity score propensity score matching randomized clinical trial receiving respiratory distress Respiratory distress syndrome Result Retrospective analysis retrospective cohort study routine care secondary Secondary outcomes significantly higher statistically significant difference study population supplementary material survival survival analysis syndrome systemic inflammation therapy two group two groups ventilator-free day Ventilator-free days was used with COVID-19
[DOI] 10.1186/s12890-021-01717-x PMC 바로가기 [Article Type] Research

Impact of the Addition of Baricitinib to Standard of Care Including Tocilizumab and Corticosteroids on Mortality and Safety in Severe COVID-19

Medicine

Published on 2021-11-082022-10-31
Journal: Frontiers in Medicine [Category] COVID-19,

[키워드] 28-day mortality 95% CI addition adjusted hazard ratio Admissions anti-inflammatory activity Antiviral association Baricitinib benefit cohort study Coinfection Combination Corticosteroid Corticosteroids COVID-19 events group Hospitalization hospitalizations hospitalized patient identify Impact IMV Including increased risk inhibitor Invasive mechanical ventilation Jak Janus kinase microbiologically Mortality not different outcome Patient patients with COVID-19 Primary outcome progression Propensity score reduce mortality Remdesivir Safety SARS-CoV-2 secondary Secondary infection significant effect Standard Standard of care therapy Thromboembolic event Thromboembolic events thrombosis Tocilizumab Trial was used with COVID-19
[DOI] 10.3389/fmed.2021.749657 PMC 바로가기 [Article Type] Medicine

Pharmacoepidemiology, Machine Learning, and COVID-19: An Intent-to-Treat Analysis of Hydroxychloroquine, With or Without Azithromycin, and COVID-19 Outcomes Among Hospitalized US Veterans

약물역학, 기계 학습 및 COVID-19: 아지트로마이신 유무에 관계없이 하이드록시클로로퀸의 치료 의도 분석 및 입원한 미국 재향 군인의 COVID-19 결과

Article

Published on 2021-11-022022-09-11
Journal: American journal of epidemiology [Category] SARS, 임상,

[키워드] 95% confidence interval administration Affair Analysis Azithromycin benefit Care cause Combination coronavirus disease Coronavirus disease 2019 COVID-19 Department Effect Effectiveness Electronic health record Evidence evidence of examined gradient boosting hazard ratio HCQ Health Health care Health care system health record Hospitalization Hospitalized Hydroxychloroquine imputation In vitro studies in vitro study in vivo increased risk indicated individual intubation machine learning Missing data National no evidence of observational study patients hospitalized pharmacoepidemiology positive Propensity score randomized clinical trial reduce reported Study design survival survival analysis tested therapy Treatment treatment of COVID-19 Treatment outcome veteran virus was used with COVID-19
[DOI] 10.1093/aje/kwab183 PMC 바로가기 [Article Type] Article

Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19

COVID-19 예방을 위한 Ad26.COV2.S 아데노바이러스 벡터 백신의 효과 분석

Article

Published on 2021-11-012022-09-11
Journal: JAMA Network Open [Category] SARS, 변종, 신약개발,

[키워드] 95% CI Ad26 Ad26.COV2.S Ad26.COV2.S vaccine age Alpha amplify build Chain Reaction Cohort cohorts composed Continuous COV2.S COVID-19 Critical Delta dose drug Drug administration effective Effectiveness Efficacy effort Electronic health record Electronic health records Ethnicity evaluate Final food Health identify IMPROVE incidence rate individuals Johnson & Johnson mass vaccination Mayo Clinic men outcome outcomes Patient patients polymerase chain polymerase chain reaction Polymerase chain reaction testing Preventing Propensity score rate ratio reducing reduction in Research Retrospective analysis SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 vaccine Sex single dose Spread study cohort System the vaccine Transparency vaccination variant variants vector ZIP Code
[DOI] 10.1001/jamanetworkopen.2021.32540 PMC 바로가기 [Article Type] Article